Rezultati - Toshimitsu Ito
- Showing 1 - 11 results of 11
-
1
Effect of tea flavonoid supplementation on the susceptibility of low-density lipoprotein to oxidative modification od Tetsuya Ishikawa, Michio Suzukawa, Toshimitsu Ito, Hiroshi Yoshida, Makoto Ayaori, Masato Nishiwaki, Atsushi Yonemura, Yukihiko Hara, H. Nakamura
Izdano 1997Artigo -
2
Clinical evaluation of an immunochromatographic IgM/IgG antibody assay and chest computed tomography for the diagnosis of COVID-19 od Kazuo Imai, Sakiko Tabata, Mayu Ikeda, Sakiko Noguchi, Yutaro Kitagawa, Masaru Matuoka, Kazuyasu Miyoshi, Norihito Tarumoto, Jun Sakai, Toshimitsu Ito, Shigefumi Maesaki, Kaku Tamura, Takuya Maeda
Izdano 2020Artigo -
3
Clinical Evaluation of Self-Collected Saliva by Quantitative Reverse Transcription-PCR (RT-qPCR), Direct RT-qPCR, Reverse Transcription–Loop-Mediated Isothermal Amplification, and... od Mayu Nagura‐Ikeda, Kazuo Imai, Sakiko Tabata, Kazuyasu Miyoshi, Nami Murahara, Tsukasa Mizuno, Midori Horiuchi, Kento Kato, Yoshitaka Imoto, Maki Iwata, Satoshi Mimura, Toshimitsu Ito, Kaku Tamura, Yasuyuki Kato
Izdano 2020Artigo -
4
ABCA1 overexpression leads to hyperalphalipoproteinemia and increased biliary cholesterol excretion in transgenic mice od Boris Vaisman, Gilles Lambert, Marcelo Amar, Charles Joyce, Toshimitsu Ito, Robert D. Shamburek, William J. Cain, Jamila Fruchart‐Najib, Edward D. Neufeld, Alan T. Remaley, H. Bryan Brewer, Silvia Santamarina-Fojo
Izdano 2001Artigo -
5
The clinical characteristics of COVID-19: a retrospective analysis of 104 patients from the outbreak on board the Diamond Princess cruise ship in Japan od Sakiko Tabata, Kazuo Imai, Shuichi Kawano, Mayu Ikeda, Tatsuya Kodama, Kazuyasu Miyoshi, Hirofumi Obinata, Satoshi Mimura, Tsutomu Kodera, Manabu Kitagaki, Michiya Sato, Satoshi Suzuki, Toshimitsu Ito, Yasuhide Uwabe, Kaku Tamura
Izdano 2020Pré-impressão -
6
Clinical characteristics of COVID-19 in 104 people with SARS-CoV-2 infection on the Diamond Princess cruise ship: a retrospective analysis od Sakiko Tabata, Kazuo Imai, Shuichi Kawano, Mayu Ikeda, Tatsuya Kodama, Kazuyasu Miyoshi, Hirofumi Obinata, Satoshi Mimura, Tsutomu Kodera, Manabu Kitagaki, Michiya Sato, Satoshi Suzuki, Toshimitsu Ito, Yasuhide Uwabe, Kaku Tamura
Izdano 2020Artigo -
7
ABCA1 overexpression leads to hyperalphalipoproteinemia and increased biliary cholesterol excretion in transgenic mice od Boris Vaisman, Gilles Lambert, Marcelo Amar, Charles Joyce, Toshimitsu Ito, Robert D. Shamburek, William J. Cain, Jamila Fruchart‐Najib, Edward D. Neufeld, Alan T. Remaley, H. Bryan Brewer, Silvia Santamarina-Fojo
Izdano 2001Artigo -
8
Antibody response patterns in COVID‐19 patients with different levels of disease severity in Japan od Kazuo Imai, Yutaro Kitagawa, Sakiko Tabata, Katsumi Kubota, Mayu Nagura‐Ikeda, Masaru Matsuoka, Kazuyasu Miyoshi, Jun Sakai, Noriomi Ishibashi, Norihito Tarumoto, Shinichi Takeuchi, Toshimitsu Ito, Shigefumi Maesaki, Kaku Tamura, Takuya Maeda
Izdano 2021Artigo -
9
ABCG2 dysfunction causes hyperuricemia due to both renal urate underexcretion and renal urate overload od Hirotaka Matsuo, Akiyoshi Nakayama, Masayuki Sakiyama, Toshinori Chiba, Seiko Shimizu, Yusuke Kawamura, Hiroshi Nakashima, Takahiro Nakamura, Yuzo Takada, Yuji Oikawa, Tappei Takada, Hirofumi Nakaoka, Junko Abe, Hiroki Inoue, Kenji Wakai, Sayo Kawai, Guang Yin, Hiroko Nakagawa, Toshimitsu Ito, Kazuki Niwa, Ken Yamamoto, Yutaka Sakurai, Hiroshi Suzuki, Tatsuo Hosoya, Kimiyoshi Ichida, Toru Shimizu, Nariyoshi Shinomiya
Izdano 2014Artigo -
10
Genome-wide association study of clinically defined gout identifies multiple risk loci and its association with clinical subtypes od Hirotaka Matsuo, Ken Yamamoto, Hirofumi Nakaoka, Akiyoshi Nakayama, Masayuki Sakiyama, Toshinori Chiba, Atsushi Takahashi, Takahiro Nakamura, Hiroshi Nakashima, Yuzo Takada, Inaho Danjoh, Seiko Shimizu, Junko Abe, Yusuke Kawamura, Sho Terashige, Hiraku Ogata, Seishiro Tatsukawa, Guang Yin, Rieko Okada, M. Emi, Mariko Naito, Atsumi Tokumasu, Hiroyuki Onoue, Keiichi Iwaya, Toshimitsu Ito, Tappei Takada, Katsuhisa Inoue, Yukio Kato, Yukio Nakamura, Yutaka Sakurai, Hiroshi Suzuki, Yoshikatsu Kanai, Tatsuo Hosoya, Nobuyuki Hamajima, Ituro Inoue, Michiaki Kubo, Kimiyoshi Ichida, Hiroshi Ooyama, Toru Shimizu, Nariyoshi Shinomiya
Izdano 2015Artigo -
11
GWAS of clinically defined gout and subtypes identifies multiple susceptibility loci that include urate transporter genes od Akiyoshi Nakayama, Hirofumi Nakaoka, Ken Yamamoto, Masayuki Sakiyama, Amara Shaukat, Yu Toyoda, Yukinori Okada, Yoichiro Kamatani, Takahiro Nakamura, Tappei Takada, Katsuhisa Inoue, Tomoya Yasujima, Hiroaki Yuasa, Yuko Shirahama, Hiroshi Nakashima, Seiko Shimizu, Toshihide Higashino, Yusuke Kawamura, Hiraku Ogata, Makoto Kawaguchi, Yasuyuki Ohkawa, Inaho Danjoh, Atsumi Tokumasu, Keiko Ooyama, Toshimitsu Ito, Takaaki Kondo, Kenji Wakai, Blanka Stibůrková, Karel Pavelká, Lisa K. Stamp, Nicola Dalbeth, Yutaka Sakurai, Hiroshi Suzuki, Makoto Hosoyamada, Shin Fujimori, Takashi Yokoo, Tatsuo Hosoya, Ituro Inoue, Atsushi Takahashi, Michiaki Kubo, Hiroshi Ooyama, Toru Shimizu, Kimiyoshi Ichida, Nariyoshi Shinomiya, Tony R. Merriman, Hirotaka Matsuo
Izdano 2016Revisão
Iskalna orodja:
Sorodne teme
Medicine
Internal medicine
Disease
Biology
Gene
Biochemistry
Coronavirus disease 2019 (COVID-19)
Infectious disease (medical specialty)
Asymptomatic
Chemistry
Cholesterol
Endocrinology
Genetics
Gout
Immunology
Pathology
Transporter
ABCA1
Antibody
Apolipoprotein B
Apolipoprotein E
Cholesteryl ester
Genetic association
Genetically modified mouse
Genome-wide association study
Genotype
Hyperuricemia
Lipoprotein
Membrane
Outbreak